FTSE All-Share
4.986,34
PKT
-9,01
PKT
-0,18
%
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 10.04.19 | Unilever Underweight | Barclays Capital | |
| 10.04.19 | Unilever Underweight | Barclays Capital | |
| 10.04.19 | Glencore Neutral | JP Morgan Chase & Co. | |
| 10.04.19 | Rio Tinto overweight | JP Morgan Chase & Co. | |
| 09.04.19 | Prudential kaufen | Morgan Stanley | |
| 09.04.19 | BP buy | Deutsche Bank AG | |
| 09.04.19 | Barclays overweight | JP Morgan Chase & Co. | |
| 09.04.19 | Vodafone Group buy | Deutsche Bank AG | |
| 09.04.19 | Prudential buy | UBS AG | |
| 08.04.19 | Lloyds Banking Group overweight | Barclays Capital | |
| 08.04.19 | HSBC Underweight | Barclays Capital | |
| 08.04.19 | Diageo buy | UBS AG | |
| 08.04.19 | Prudential Neutral | JP Morgan Chase & Co. | |
| 05.04.19 | GSK Hold | Deutsche Bank AG | |
| 05.04.19 | AstraZeneca buy | Deutsche Bank AG | |
| 05.04.19 | Prudential buy | UBS AG | |
| 05.04.19 | Vodafone Group overweight | Barclays Capital | |
| 04.04.19 | GSK Neutral | UBS AG | |
| 04.04.19 | Barclays buy | HSBC | |
| 03.04.19 | AstraZeneca buy | Kepler Cheuvreux | |
| 03.04.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 03.04.19 | Prudential overweight | Barclays Capital | |
| 02.04.19 | Diageo overweight | Barclays Capital | |
| 02.04.19 | AstraZeneca Sell | UBS AG | |
| 02.04.19 | London Stock Exchange (LSE) overweight | JP Morgan Chase & Co. | |
| 02.04.19 | AstraZeneca Reduce | HSBC | |
| 01.04.19 | AstraZeneca overweight | Barclays Capital | |
| 01.04.19 | AstraZeneca Neutral | UBS AG | |
| 01.04.19 | Unilever Neutral | UBS AG | |
| 01.04.19 | Unilever Neutral | UBS AG | |
| 01.04.19 | Rio Tinto Underperform | RBC Capital Markets | |
| 01.04.19 | AstraZeneca buy | Deutsche Bank AG | |
| 30.03.19 | AstraZeneca Outperform | Credit Suisse Group | |
| 29.03.19 | AstraZeneca overweight | Barclays Capital | |
| 29.03.19 | Barclays buy | HSBC | |
| 29.03.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 29.03.19 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 29.03.19 | Rio Tinto overweight | JP Morgan Chase & Co. | |
| 27.03.19 | Rio Tinto Neutral | UBS AG | |
| 25.03.19 | London Stock Exchange (LSE) Neutral | UBS AG |